Skip to main content
. 2011 Apr 19;10:42. doi: 10.1186/1476-4598-10-42

Figure 2.

Figure 2

Antitumour efficacy of the single mAbs in the intraperitoneal JOK1-5.3 model. Kaplan-Meier curves showing survival fractions of SCID mice intraperitoneally grafted with JOK1-5.3 cells and treated with 2 i.p. injections at day 1 and 4 of 0.5 mg of mAbs anti-CD5, Anti-CD71, anti-HLA-DR and rituximab. Controls were either untreated mice (PBS) or mice treated with an irrelevant mouse IgG1 isotype. (All treated groups were significantly different from the control groups p < 0.005). The study was performed twice. Data are presented as cumulative percentage of both experiments.